Non-animal protein Opportunity to pursue partnerships and licensing for scalable, animal-free protein production platforms targeted at life sciences, food and nutrition, and bio-industrial markets, leveraging Dyadic's C1 and Dapibus platforms.

Industrial enzymes Target collaborations and OEM/Co-development deals around the new proprietary industrial enzyme program for advanced cellulose processing, appealing to biofuel, paper, and textile sectors seeking sustainable enzyme solutions.

Global expansion Leverage recent expansion in Japan and Asia to pursue regional distribution, co-development, and market-entry partnerships with local biotechs and contract manufacturers to accelerate geographic reach.

Clinical and biopharma Explore OEM distribution and license opportunities with contract research and manufacturing organizations (CROs/CMOs) and biopharma players needing scalable recombinant proteins, vaccines, and enzymes at lower cost and higher throughput.

Strategic collaborations Capitalize on recent collaborations and development licenses in dairy proteins and IBT Bioservices to identify additional joint development opportunities across life sciences, food tech, and bioprocessing markets.